|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.60 SEK | +0.79% |
|
-5.20% | -0.47% |
| 06-12 | Handelsbanken Fonder increases stake in Alligo to just over 5 percent | FW |
| 06-08 | Espiria Sweden Small Cap rose 6.1 percent in May - Hansa Biopharma contributed positively | FW |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 1.05B | 2.71% | 4.89% | 7% | - | 2.9x | |
| 17.94B | 9.51% | 15% | 48.5% | 21.38% | 0.65x | |
| 8.2B | 15.35% | 20.19% | 33.29% | 25.81% | -0.08x | |
| 2.05B | 12.13% | 22.48% | 25.14% | 13.18% | 0.83x | |
| 4.56B | 8.61% | 10.92% | 22.24% | 12.83% | 0.33x | |
| 7.65B | 5.77% | 9.44% | 23.87% | 7.38% | 2.09x | |
| 3.77B | 5.29% | 8.38% | 14.34% | 8.1% | 1.06x | |
| 3.8B | 5.62% | 9.2% | 11.7% | 6.12% | 1.01x | |
| 876M | 7.76% | 12% | 15.8% | - | 2.69x | |
| 2.02B | 4.39% | 8.77% | 19.23% | 5.84% | 2.58x | |
| 2.82B | -3.16% | 5.04% | - | - | - | |
| 1.98B | 0.42% | 3.95% | - | - | - | |
| 3.41B | 1.72% | 2.22% | 7% | 4.04% | - | |
| 2.04B | 4.96% | 7.13% | 8.8% | 7.79% | 1.14x | |
| 522M | 4.61% | 8.41% | 12% | - | 2.62x | |
| 1.38B | 4.54% | 6.25% | 11.7% | 8.27% | - | |
| 682M | 6.92% | 7.4% | 14.8% | 5.53% | - | |
| Average | 3.81B | 5.71% | 9.51% | 18.36% | 10.52% | 1.48x | |
| Weighted average by Cap. | 10.35B | 10.53% | 15.61% | 34.9% | 19.5% | 0.58x |
- Stock Market
- Stocks
- ALLIGO B Stock
- Sector Alligo AB
- Financial comparisons
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
